Elevance Health, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Elevance Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 5.0 times. Higher than 87% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
$103Over the last 3 years, every $100 of reported profit came with $103 of operating cash.
Lower than 84% of Healthcare companies in United States.
Self-Funding Ratio
5.0×Over the last 3 years its own operating cash covered its investment spending (capex) 5.0 times.
Higher than 87% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$1Sales grew 27% in 3 years, but profit fell: $1 less profit per $100 of extra sales.
Lower than 68% of Healthcare companies in United States.
Asset Productivity Ratio
+27% / +18%In 3 years sales changed by +27% while total assets changed by +18%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
3.4×Debt due within a year is covered 3.4 times by its yearly operating cash.
Higher than 78% of Healthcare companies in United States.
Cash Cushion Ratio
+3%Cash, after subtracting all debt, equals 3% of its market value (net cash).
Lower than 61% of Healthcare companies in United States.
Tangible Assets Ratio
67%Of every $100 the company owns, $67 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 64% of Healthcare companies in United States.
Tangible Net Worth Ratio
10%Of every $100 of net worth, $10 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 69% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Elevance Health, Inc. owes $0.64 for every $1 it owns. Net profit fell 5% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
18.9Investors pay $18.9 for every $1 of Elevance Health, Inc.'s yearly profit, lower than 66% of Healthcare companies in United States.
P/B ratio
2.15The share price is 2.15 times Elevance Health, Inc.'s book value per share, lower than 55% of Healthcare companies in United States.
Market cap
$96.6 BThe total market value of all of Elevance Health, Inc.'s shares at today's price (share price × number of shares), larger than 98% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$44.9 BWhat Elevance Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$206.96Net worth divided by the number of shares. The share price of $445.28 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
11.1%Elevance Health, Inc. earned 11.1% on its shareholders' money over the last year, higher than 84% of Healthcare companies in United States.
Owes vs Owns
0.64×Elevance Health, Inc. owes $0.64 for every $1 it owns (moderate), higher than 68% of Healthcare companies in United States.
Dividend yield
1.58%Elevance Health, Inc. pays 1.58% of its share price as dividends a year, higher than 66% of dividend-paying Healthcare companies in United States.
Revenue growth
+13%Revenue rose 13% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Profit growth
-5%Net profit fell 5% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Profit margin
2.8%Elevance Health, Inc. keeps $3 of every $100 of revenue as net profit.
Cash quality
0.8×Cash from Elevance Health, Inc.'s business was 0.8× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.
Cash vs debt
Net cashElevance Health, Inc. held $3.3 B more cash than debt (net cash) at Dec 2025.
Questions
What is Elevance Health, Inc.'s P/E ratio?
Investors pay $18.9 for every $1 of Elevance Health, Inc.'s yearly profit, lower than 66% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Elevance Health, Inc.: $96.6 B ÷ $44.9 B (30 Jun 2026) = 2.2.
What is Elevance Health, Inc.'s return on equity?
Elevance Health, Inc. earned 11.1% on its shareholders' money over the last year, higher than 84% of Healthcare companies in United States.
How much does Elevance Health, Inc. owe compared with what it owns?
Elevance Health, Inc. owes $0.64 for every $1 it owns (moderate), higher than 68% of Healthcare companies in United States.
Does Elevance Health, Inc. pay a dividend?
Yes. Elevance Health, Inc. pays 1.58% of its share price as dividends a year, higher than 66% of dividend-paying Healthcare companies in United States.
Is Elevance Health, Inc.'s revenue growing?
Revenue rose 13% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.